Retatrutide, a Triple Agonist, Explored for Kidney Parameter Modulation in Type 2 Diabetes
Obesity Treatment to Improve Diabetes
Abstract
Retatrutide, a GIP/GLP-1/glucagon receptor agonist, was assessed for its impact on kidney parameters in patients with type 2 diabetes mellitus (T2D) and kidney disease.